Loading...
XASXALC
Market cap50mUSD
Jan 08, Last price  
0.06AUD
1D
1.69%
1Q
3.45%
Jan 2017
-31.03%
IPO
-65.30%
Name

Alcidion Group Ltd

Chart & Performance

D1W1MN
XASX:ALC chart
P/E
—
P/S
2.17
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
9.89%
Rev. gr., 5y
17.05%
Revenues
37m
-8.27%
0107,621110,2452,366,8765,181,2584,024,9643,458,1114,179,48716,864,32318,551,26325,882,00034,355,00040,400,00037,057,000
Net income
-8m
L+132.71%
0-3,108,021-1,193,789-148,588-278,421-2,544,717-2,060,979-2,089,313-84,165-3,076,596-2,244,000-4,412,000-3,617,000-8,417,000
CFO
-7m
L
0001,129,325-2,629,242-519,422-1,825,3051,990,959-2,017,1761,545,000996,000169,000-7,129,000
Earnings
Feb 20, 2025

Profile

Alcidion Group Limited, together with its subsidiaries, engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom. The company offers Miya Precision, a consolidated fast healthcare interoperability resource (FHIR) based platform to deliver smart healthcare; Smartpage, a smartphone and web-based system for hospital communication and task management to address the requirements of clinical and non-clinical users; Patientrack, a real-time patient monitoring and risk screening solution; Silverlink, a patient administration system; and ExtraMed, a clinical and patient flow management software. It also provides product implementation, product support and maintenance, systems integration, and data analysis services. The company was formerly known as Alcidion Corporation Pty Ltd and changed its name to Alcidion Group Limited in December 2015. Alcidion Group Limited was founded in 2000 and is headquartered in South Yarra, Australia.
URL
https://www.alcidion.com/
IPO date
Jun 24, 2011
Employees
191
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
37,057
-8.27%
40,400
17.60%
34,355
32.74%
Cost of revenue
34,333
40,963
32,737
Unusual Expense (Income)
NOPBT
2,724
(563)
1,618
NOPBT Margin
7.35%
4.71%
Operating Taxes
(282)
(1,123)
504
Tax Rate
31.15%
NOPAT
3,006
560
1,114
Net income
(8,417)
132.71%
(3,617)
-18.02%
(4,412)
96.61%
Dividends
Dividend yield
Proceeds from repurchase of equity
5,403
51,942
BB yield
-8.55%
-40.56%
Debt
Debt current
697
693
616
Long-term debt
2,693
2,924
3,736
Deferred revenue
(1)
Other long-term liabilities
591
577
141
Net debt
(8,408)
(11,024)
(12,987)
Cash flow
Cash from operating activities
(7,129)
169
996
CAPEX
(53)
(454)
(311)
Cash from investing activities
(53)
(3,141)
(59,743)
Cash from financing activities
4,342
(616)
51,333
FCF
3,909
955
(1,605)
Balance
Cash
11,798
14,641
17,339
Long term investments
Excess cash
9,945
12,621
15,621
Stockholders' equity
86,940
90,165
93,955
Invested Capital
79,281
80,276
80,471
ROIC
3.77%
0.70%
2.21%
ROCE
2.84%
1.55%
EV
Common stock shares outstanding
1,316,215
1,268,069
1,164,272
Price
0.05
-49.47%
0.10
-13.64%
0.11
-72.50%
Market cap
63,178
-47.56%
120,467
-5.94%
128,070
-68.62%
EV
54,770
109,443
115,083
EBITDA
6,824
2,624
3,874
EV/EBITDA
8.03
41.71
29.71
Interest
103
125
68
Interest/NOPBT
3.78%
4.20%